Market Place
Sourcing Support
Sonoma Biotherapeutics Receives $45M Regeneron Milestone
04 Sep 2024 //
CONTRACT PHARMA
Sonoma to Present Data from Novel Treg Therapy for Rheumatoid Arthritis
06 Nov 2023 //
BUSINESSWIRE
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy
13 Oct 2023 //
BUSINESSWIRE
Sonoma Biotherapeutics Appoints Joseph R. Arron as Chief Scientific Officer
29 Sep 2023 //
BUSINESSWIRE
Sonoma Bio Co-Founder & Chief Executive Officer Jeffrey Bluestone, Ph.D
04 May 2023 //
BUSINESSWIRE
Sonoma and Regeneron Announce Collaboration for Autoimmune Diseases
28 Mar 2023 //
BUSINESSWIRE
Sonoma inks $120M Regeneron collab, tacking on up to 5 targets
28 Mar 2023 //
FIERCE BIOTECH
Sonoma to Present Preclinical Data from Novel Treg Cell Therapy for Rheumatoid
10 Nov 2022 //
BUSINESSWIRE
Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer
07 Sep 2022 //
BUSINESSWIRE
Sonoma Bio to cement its roots in Seattle with a new manufacturing and R&D site
24 Aug 2022 //
ENDPTS
Sonoma Biotherapeutics Announces FDA Clearance of IND Application for SBT115301
08 Jun 2022 //
BUSINESSWIRE
Sonoma Biotherapeutics Appoints Heidi Hagen as Chief Technical Officer
16 Nov 2021 //
BUSINESSWIRE
Sonoma Biotherapeutics Appoints Doug Sheehy, as Chief Legal Officer & Secretary
16 Sep 2021 //
BUSINESSWIRE
Sonoma Bio bags $265M for arthritis, diabetes cell therapies
04 Aug 2021 //
FIERCEBIOTECH
Sonoma Raises $265 Million in an Oversubscribed Series B Financing
04 Aug 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.